These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11566710)

  • 1. Allergic reactions to gadolinium chelates.
    Runge VM
    AJR Am J Roentgenol; 2001 Oct; 177(4):944-5. PubMed ID: 11566710
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction.
    Martin DR
    Top Magn Reson Imaging; 2016 Dec; 25(6):255. PubMed ID: 27849655
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
    Heshmatzadeh Behzadi A; Prince MR
    Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
    Thomsen HS
    Top Magn Reson Imaging; 2016 Dec; 25(6):269-274. PubMed ID: 27849654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2008 Jan; 190(1):187-90. PubMed ID: 18094310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
    Carr TF
    Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
    Reimer P; Vosshenrich R
    Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Stability" of gadolinium chelates.
    Tweedle MF
    Br J Radiol; 2007 Jul; 80(955):583-4; author reply 584-5. PubMed ID: 17704319
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of gadolinium chelates as an alternative radiographic contrast agent for use with flat panel detector angiography.
    Hui FK; Tong FC; Dion JE
    J Neurointerv Surg; 2011 Mar; 3(1):95-7. PubMed ID: 21990800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-Based Contrast Agents: Associated Adverse Reactions.
    Ramalho M; Ramalho J
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):755-764. PubMed ID: 28964465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of negative skin tests to gadolinium contrast agents.
    Chiriac AM; Audurier Y; Bousquet PJ; Demoly P
    Allergy; 2011 Nov; 66(11):1504-6. PubMed ID: 21854399
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach.
    Tonolini M; Bianco R
    Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of adverse drug reaction in patients with allergic diseases].
    Tsurikisawa N; Akiyama K
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():48-52. PubMed ID: 18074516
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of magnetic resonance contrast media.
    Runge VM
    Top Magn Reson Imaging; 2001 Aug; 12(4):309-14. PubMed ID: 11687717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to gadolinium contrast media: a review of 36 cases.
    Murphy KJ; Brunberg JA; Cohan RH
    AJR Am J Roentgenol; 1996 Oct; 167(4):847-9. PubMed ID: 8819369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.
    Idée JM; Port M; Medina C; Lancelot E; Fayoux E; Ballet S; Corot C
    Toxicology; 2008 Jun; 248(2-3):77-88. PubMed ID: 18440117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
    Boehm I; Hungerbühler M; Heverhagen JT
    Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based Contrast Media by Skin Tests 10 Years After Onset.
    Harr T; Jandus P
    J Investig Allergol Clin Immunol; 2018 Jun; 28(3):203-205. PubMed ID: 29939144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.